These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31587570)

  • 21. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians.
    Johnson CB; Sulpher J; Stadnick E
    Curr Opin Cardiol; 2015 Mar; 30(2):197-204. PubMed ID: 25574894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology.
    Chen M; Xue J; Wang M; Yang J; Chen T
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncology and Cardiac Rehabilitation: An Underrated Relationship.
    Venturini E; Iannuzzo G; D'Andrea A; Pacileo M; Tarantini L; Canale ML; Gentile M; Vitale G; Sarullo FM; Vastarella R; Di Lorenzo A; Testa C; Parlato A; Vigorito C; Giallauria F
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32532011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
    Fatunde OA; Brown SA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuating Treatment-Related Cardiotoxicity in Women Recently Diagnosed With Breast Cancer via a Tailored Therapeutic Exercise Program: Protocol of the ATOPE Trial.
    Postigo-Martin P; Peñafiel-Burkhardt R; Gallart-Aragón T; Alcaide-Lucena M; Artacho-Cordón F; Galiano-Castillo N; Fernández-Lao C; Martín-Martín L; Lozano-Lozano M; Ruíz-Vozmediano J; Moreno-Gutiérrez S; Illescas-Montes R; Arroyo-Morales M; Cantarero-Villanueva I
    Phys Ther; 2021 Mar; 101(3):. PubMed ID: 33528004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
    Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R
    Intern Med J; 2021 Feb; 51(2):229-234. PubMed ID: 31841257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review.
    Zoth N; Tomanek A; Seuthe K; Pfister R; Baumann FT
    Oncol Res Treat; 2023; 46(4):131-139. PubMed ID: 36652921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and proposal for cardio-oncology services in Italy.
    Galderisi M; Santoro C; Bossone E; Mancusi C
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):207-215. PubMed ID: 32858628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities for improved cardiovascular disease prevention in oncology patients.
    Bravo-Jaimes K; Marcellon R; Varanitskaya L; Kim PY; Iliescu C; Gilchrist SC; Baldassarre LA; Manisty C; Ghosh AK; Guha A; Lopez-Mattei JC
    Curr Opin Cardiol; 2020 Sep; 35(5):531-537. PubMed ID: 32649353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors.
    Batalik L; Filakova K; Radkovcova I; Dosbaba F; Winnige P; Vlazna D; Batalikova K; Felsoci M; Stefanakis M; Liska D; Papathanasiou J; Pokorna A; Janikova A; Rutkowski S; Pepera G
    Front Cardiovasc Med; 2022; 9():858334. PubMed ID: 35497988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors.
    Sase K; Kida K; Furukawa Y
    J Cardiol; 2020 Dec; 76(6):559-567. PubMed ID: 32736905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescribing, dosing and titrating exercise in patients with hypertrophic cardiomyopathy for prevention of comorbidities: Ready for prime time.
    Cavigli L; Olivotto I; Fattirolli F; Mochi N; Favilli S; Mondillo S; Bonifazi M; D'Ascenzi F
    Eur J Prev Cardiol; 2021 Aug; 28(10):1093-1099. PubMed ID: 33611579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations for cardiovascular rehabilitation in the very elderly].
    Vigorito C; Incalzi RA; Acanfora D; Marchionni N; Fattirolli F;
    Monaldi Arch Chest Dis; 2003 Mar; 60(1):25-39. PubMed ID: 12827830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate exercise prescription in primary and secondary prevention of cardiovascular disease: why this skill remains to be improved among clinicians and healthcare professionals. A call for action from the EXPERT Network†.
    Hansen D; Coninx K; Beckers P; Cornelissen V; Kouidi E; Neunhauserer D; Niebauer J; Spruit MA; Takken T; Dendale P
    Eur J Prev Cardiol; 2023 Dec; 30(18):1986-1995. PubMed ID: 37458001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise, cancer and cardiovascular disease: what should clinicians advise?
    Zimmerman A; Planek MIC; Chu C; Oyenusi O; Paner A; Reding K; Skeete J; Clark B; Okwuosa TM
    Cardiovasc Endocrinol Metab; 2021 Jun; 10(2):62-71. PubMed ID: 34113793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies.
    Bychowski J; Sobiczewski W
    Cancer Med; 2023 Jul; 12(13):14545-14555. PubMed ID: 37102247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardio-Oncology Rehabilitation (CORE) Exercise Prescription and Programming: A PRACTICAL GUIDE.
    Shultz AM; Squires RW; Shin JY; Durani U; Pophali PA
    J Cardiopulm Rehabil Prev; 2021 Sep; 41(5):341-344. PubMed ID: 34461622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.